141 related articles for article (PubMed ID: 7811035)
1. Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing.
Brummer E; Nassar F; Stevens DA
Antimicrob Agents Chemother; 1994 Sep; 38(9):2158-61. PubMed ID: 7811035
[TBL] [Abstract][Full Text] [Related]
2. Macrophage colony-stimulating factor induction of enhanced macrophage anticryptococcal activity: synergy with fluconazole for killing.
Brummer E; Stevens DA
J Infect Dis; 1994 Jul; 170(1):173-9. PubMed ID: 8014494
[TBL] [Abstract][Full Text] [Related]
3. Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing.
Nassar F; Brummer E; Stevens DA
Cell Immunol; 1995 Aug; 164(1):113-8. PubMed ID: 7634342
[TBL] [Abstract][Full Text] [Related]
4. Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans.
Nassar F; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1994 Sep; 38(9):2162-4. PubMed ID: 7811036
[TBL] [Abstract][Full Text] [Related]
5. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.
Natarajan U; Randhawa N; Brummer E; Stevens DA
J Med Microbiol; 1998 Apr; 47(4):359-63. PubMed ID: 9569003
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antifungal effect of fluconazole and human polymorphonuclear leukocytes on Paracoccidioides brasiliensis: effect of interferon-gamma and granulocyte-macrophage colony-stimulating factor.
Kurita N; Brummer E; Oarada M; Miyaji M
Med Mycol; 2003 Apr; 41(2):131-6. PubMed ID: 12964845
[TBL] [Abstract][Full Text] [Related]
7. Synergy of fluconazole with macrophages for antifungal activity against Candida albicans.
Garcha UK; Brummer E; Stevens DA
Mycopathologia; 1995-1996; 132(3):123-8. PubMed ID: 8684425
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro effects of macrophage colony-stimulating factor (M-CSF) on bronchoalveolar macrophages for antihistoplasmal activity.
Khemani S; Brummer E; Stevens DA
Int J Immunopharmacol; 1995 Jan; 17(1):49-53. PubMed ID: 7782153
[TBL] [Abstract][Full Text] [Related]
9. Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia.
Brummer E; Maqbool A; Stevens DA
Med Mycol; 2001 Dec; 39(6):509-15. PubMed ID: 11798056
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
Levitz SM; DiBenedetto DJ
J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
[TBL] [Abstract][Full Text] [Related]
11. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients.
Tascini C; Vecchiarelli A; Preziosi R; Francisci D; Bistoni F; Baldelli F
AIDS; 1999 Jan; 13(1):49-55. PubMed ID: 10207544
[TBL] [Abstract][Full Text] [Related]
13. Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro.
Alcouloumre MS; Ghannoum MA; Ibrahim AS; Selsted ME; Edwards JE
Antimicrob Agents Chemother; 1993 Dec; 37(12):2628-32. PubMed ID: 8109927
[TBL] [Abstract][Full Text] [Related]
14. Development of macrophage anticryptococcal activity in vitro is dependent on endogenous M-CSF.
Brummer E; Gilmore GL; Shadduck RK; Stevens DA
Cell Immunol; 1998 Nov; 189(2):144-8. PubMed ID: 9790728
[TBL] [Abstract][Full Text] [Related]
15. Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages for Histoplasma capsulatum.
Brummer E; Stevens DA
Clin Exp Immunol; 1995 Oct; 102(1):65-70. PubMed ID: 7554402
[TBL] [Abstract][Full Text] [Related]
16. Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity.
Nassar F; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1995 Nov; 39(11):2490-3. PubMed ID: 8585731
[TBL] [Abstract][Full Text] [Related]
17. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
Chiller T; Farrokhshad K; Brummer E; Stevens DA
Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010
[TBL] [Abstract][Full Text] [Related]
18. Killing of Histoplasma capsulatum by macrophage colony stimulating factor-treated human monocyte-derived macrophages: role for reactive oxygen intermediates.
Desai G; Nassar F; Brummer E; Stevens DA
J Med Microbiol; 1995 Sep; 43(3):224-9. PubMed ID: 7650732
[TBL] [Abstract][Full Text] [Related]
19. Anticryptococcal activity of voriconazole against Cryptococcus neoformans var. gatti vs var. neoformans: comparison with fluconazole and effect of human serum.
Brummer E; Kamei K; Miyaji M
Mycopathologia; 1998; 142(1):3-7. PubMed ID: 9850592
[TBL] [Abstract][Full Text] [Related]
20. Synergy of human neutrophils with fluconazole in killing Candida species.
Brummer E; Stevens DA
Mycopathologia; 1996; 134(3):115-20. PubMed ID: 8981777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
